Pembrolizumab: Living up to expectations

Stephen M. Ansell

doi:10.1182/blood.2019002417

Pembrolizumab: Living up to expectations

Stephen M. Ansell

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1114-1115
Number of pages	2
Journal	Blood
Volume	134
Issue number	14
DOIs	https://doi.org/10.1182/blood.2019002417
State	Published - Oct 3 2019

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2019002417

Cite this

@article{d7123a8eb2ff451a956fefc1fcab8e85,

title = "Pembrolizumab: Living up to expectations",

author = "Ansell, {Stephen M.}",

year = "2019",

month = oct,

day = "3",

doi = "10.1182/blood.2019002417",

language = "English (US)",

volume = "134",

pages = "1114--1115",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

TY - JOUR

T1 - Pembrolizumab

T2 - Living up to expectations

AU - Ansell, Stephen M.

PY - 2019/10/3

Y1 - 2019/10/3

UR - http://www.scopus.com/inward/record.url?scp=85072919928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072919928&partnerID=8YFLogxK

U2 - 10.1182/blood.2019002417

DO - 10.1182/blood.2019002417

M3 - Comment/debate

C2 - 31582369

AN - SCOPUS:85072919928

SN - 0006-4971

VL - 134

SP - 1114

EP - 1115

JO - Blood

JF - Blood

IS - 14

ER -

Pembrolizumab: Living up to expectations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this